Cargando…
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study
Post-marketing surveillance activities are essential to detect the risk/benefit profile of biologic disease-modifying antirheumatic drugs (bDMARDs) in inflammatory arthritis. The aim of this study was to evaluate adverse events (AEs) in patients treated with bDMARDs in rheumatology during a prospect...
Autores principales: | Barbieri, Maria Antonietta, Cicala, Giuseppe, Cutroneo, Paola Maria, Gerratana, Elisabetta, Palleria, Caterina, De Sarro, Caterina, Vero, Ada, Iannone, Luigi, Manti, Antonia, Russo, Emilio, De Sarro, Giovambattista, Atzeni, Fabiola, Spina, Edoardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230621/ https://www.ncbi.nlm.nih.gov/pubmed/32344563 http://dx.doi.org/10.3390/jcm9041227 |
Ejemplares similares
-
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study
por: Iannone, Luigi Francesco, et al.
Publicado: (2020) -
Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region
por: Gagliardi, Agnese, et al.
Publicado: (2022) -
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP)
por: Palleria, Caterina, et al.
Publicado: (2018) -
Serological Response to SARS-CoV-2 Messenger RNA Vaccine: Real-World Evidence from Italian Adult Population
por: Papadopoli, Rosa, et al.
Publicado: (2021) -
Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2022)